| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
47,303,000 |
| Market
Cap: |
1.03(B) |
| Last
Volume: |
83,298 |
Avg
Vol: |
83,070 |
| 52
Week Range: |
$8.99 - $24.34 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile BioLife Solutions develops, manufactures, and markets bioproduction tools and services to the cell and gene therapy industry and biopharma market. Co.'s bioproduction tools and services are comprised of three lines that contain seven main offerings: cell processing, which includes biopreservation media and human platelet lysate media, cryogenic vials, and automated cell-processing fill machines; freezers and thaw systems, which include ultra-low temperature freezers, cryogenic freezers and accessories, and automated thawing devices; and storage and cold chain services, which include biological and pharmaceutical material storage and cloud connected smart shipping containers.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
985,630 |
1,135,630 |
| Total Buy Value |
$0 |
$0 |
$11,146,720 |
$14,414,913 |
| Total People Bought |
0 |
0 |
1 |
1 |
| Total Buy Transactions |
0 |
0 |
2 |
7 |
| Total Shares Sold |
83,754 |
101,171 |
232,072 |
567,047 |
| Total Sell Value |
$1,452,468 |
$1,732,476 |
$3,579,773 |
$10,745,200 |
| Total People Sold |
8 |
8 |
10 |
11 |
| Total Sell Transactions |
33 |
57 |
105 |
227 |
| End Date |
2024-02-29 |
2023-11-28 |
2023-05-30 |
2022-05-30 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Aebersold Sarah |
VP, Global Human Resources |
• • – |
2022-01-20 |
4 |
S |
$30.24 |
$10,040 |
D/D |
(332) |
19,236 |
|
53% |
|
| Schulz Marcus |
Chief Revenue Officer |
• • – |
2022-01-20 |
4 |
S |
$30.24 |
$11,945 |
D/D |
(395) |
28,391 |
|
53% |
|
| Schulz Marcus |
Chief Revenue Officer |
• • – |
2022-01-12 |
4 |
S |
$32.18 |
$8,592 |
D/D |
(267) |
28,786 |
|
59% |
|
| Rice Michael |
CEO |
• • – |
2022-01-12 |
4 |
AS |
$31.72 |
$528,646 |
D/D |
(16,666) |
259,455 |
|
-59% |
|
| Rice Michael |
CEO |
• • – |
2022-01-12 |
4 |
OE |
$1.78 |
$29,665 |
D/D |
16,666 |
276,121 |
|
- |
|
| Rice Michael |
CEO |
• • – |
2022-01-10 |
4 |
AS |
$30.83 |
$513,813 |
D/D |
(16,666) |
259,455 |
|
-62% |
|
| Rice Michael |
CEO |
• • – |
2022-01-10 |
4 |
OE |
$1.78 |
$29,665 |
D/D |
16,666 |
276,121 |
|
- |
|
| De Greef Roderick |
COO & President |
• • – |
2022-01-07 |
4 |
S |
$30.75 |
$332,592 |
D/D |
(10,816) |
91,812 |
|
62% |
|
| Wichterman Troy |
Chief Financial Officer |
• • – |
2022-01-07 |
4 |
S |
$30.75 |
$1,445 |
D/D |
(47) |
22,075 |
|
62% |
|
| Mathew Aby J. |
EVP & Chief Scientific Officer |
• • – |
2022-01-05 |
4 |
AS |
$34.30 |
$269,495 |
D/D |
(7,857) |
206,014 |
|
-61% |
|
| Mathew Aby J. |
EVP & Chief Scientific Officer |
• • – |
2022-01-05 |
4 |
OE |
$1.40 |
$11,000 |
D/D |
7,857 |
213,871 |
|
- |
|
| Mathew Aby J. |
EVP & Chief Scientific Officer |
• • – |
2022-01-04 |
4 |
AS |
$35.06 |
$350,600 |
D/D |
(10,000) |
206,014 |
|
-65% |
|
| Mathew Aby J. |
EVP & Chief Scientific Officer |
• • – |
2022-01-04 |
4 |
OE |
$1.40 |
$14,000 |
D/D |
10,000 |
216,014 |
|
- |
|
| De Greef Roderick |
COO & President |
• • – |
2021-12-29 |
4 |
S |
$39.37 |
$27,756 |
D/D |
(705) |
102,628 |
|
72% |
|
| Rice Michael |
CEO |
• • – |
2021-12-29 |
4 |
S |
$39.37 |
$36,535 |
D/D |
(928) |
259,455 |
|
72% |
|
| Foster Karen A. |
Chief Quality Officer |
• • – |
2021-12-29 |
4 |
S |
$39.37 |
$24,606 |
D/D |
(625) |
69,820 |
|
72% |
|
| Berard Todd |
Chief Marketing Officer |
• • – |
2021-12-29 |
4 |
S |
$39.37 |
$20,354 |
D/D |
(517) |
77,147 |
|
72% |
|
| Mathew Aby J. |
EVP & Chief Scientific Officer |
• • – |
2021-12-29 |
4 |
S |
$39.37 |
$28,976 |
D/D |
(736) |
206,014 |
|
72% |
|
| Wichterman Troy |
Chief Financial Officer |
• • – |
2021-12-22 |
4 |
S |
$38.49 |
$11,932 |
D/D |
(310) |
22,122 |
|
66% |
|
| Rice Michael |
CEO |
• • – |
2021-12-15 |
4 |
AS |
$32.80 |
$546,645 |
D/D |
(16,666) |
260,383 |
|
-63% |
|
| Rice Michael |
CEO |
• • – |
2021-12-15 |
4 |
OE |
$1.78 |
$29,665 |
D/D |
16,666 |
277,049 |
|
- |
|
| Rice Michael |
CEO |
• • – |
2021-12-13 |
4 |
AS |
$33.82 |
$563,644 |
D/D |
(16,666) |
260,383 |
|
-60% |
|
| Rice Michael |
CEO |
• • – |
2021-12-13 |
4 |
OE |
$1.78 |
$29,665 |
D/D |
16,666 |
277,049 |
|
- |
|
| Rice Michael |
CEO |
• • – |
2021-12-09 |
4 |
AS |
$35.15 |
$402,960 |
D/D |
(11,464) |
260,383 |
|
-61% |
|
| Rice Michael |
CEO |
• • – |
2021-12-09 |
4 |
OE |
$1.64 |
$18,801 |
D/D |
11,464 |
271,847 |
|
- |
|
1275 Records found
|
|
Page 19 of 51 |
|
|
0.16 (0.74%) 
